Vanessa Hebditch
YOU?
Author Swipe
View article: Hepatocellular carcinoma surveillance: minimum standards
Hepatocellular carcinoma surveillance: minimum standards Open
Hepatocellular carcinoma (HCC) is a rapidly growing cause of cancer-related deaths in the UK, with early detection being critical for improving survival rates. Despite clear guidelines recommending 6-monthly surveillance for at-risk popula…
View article: Increasing engagement with liver disease management across the UK: a follow-up cross-sectional survey
Increasing engagement with liver disease management across the UK: a follow-up cross-sectional survey Open
Background Liver disease is an increasing cause of premature mortality. Early detection of liver disease in primary care gives opportunity to intervene and change outcomes. Engagement in liver disease care by NHS bodies responsible for pri…
View article: Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group
Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group Open
Objective Alcohol-related liver disease (ALD) is the most common cause of liver-related ill health and liver-related deaths in the UK, and deaths from ALD have doubled in the last decade. The management of ALD requires treatment of both li…
View article: Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group Open
Summary
\nNon-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the general population. The evidence base for the investigation and management of NAFLD is large and growing, but there is currently little pract…
View article: Advancing the global public health agenda for NAFLD: a consensus statement
Advancing the global public health agenda for NAFLD: a consensus statement Open
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implic…
View article: P028 Chronic liver disease, platelet transfusion & quality of life – a British liver trust patient-survey
P028 Chronic liver disease, platelet transfusion & quality of life – a British liver trust patient-survey Open
Introduction For patients with chronic liver disease, thrombocytopenia is a common complication that impacts on management of cirrhosis and has implications for planned surgical/diagnostic procedures due to an increased risk of bleeding. P…
View article: Engagement with community liver disease management across the UK: a cross-sectional survey
Engagement with community liver disease management across the UK: a cross-sectional survey Open
Background Liver disease is an increasing cause of premature mortality in the UK. Its management in primary care is not well understood. It is unclear what role commissioning bodies are playing in liver disease in the UK. Aim To assess the…
View article: Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study.
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. Open
View article: Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study Open
View article: Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology
Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology Open
Liver biopsy is required when clinically important information about the diagnosis, prognosis or management of a patient cannot be obtained by safer means, or for research purposes. There are several approaches to liver biopsy but predomin…
View article: The Cost of Non-Alcoholic Steatohepatitis (NASH) in Europe and USA: The GAIN Study
The Cost of Non-Alcoholic Steatohepatitis (NASH) in Europe and USA: The GAIN Study Open